Le Travenues Know-how Ltd, which operates journey platform Ixigo, has acquired markets regulator Sebi’s go-ahead to lift ₹1,600 crore via an preliminary share-sale.
Aside from this, cardiac stent maker Sahajanand Medical Applied sciences and meals and beverage main Keventer Agro have acquired regulatory approval from Sebi to drift their preliminary public choices (IPOs).
These three corporations, which filed their preliminary IPO papers with Sebi between August and September, obtained commentary letter from the regulator throughout December 16-17, an replace with the markets watchdog confirmed on Monday.
In Sebi parlance, the issuance of commentary letter implies its go-ahead for the IPO.
Going by the draft papers, Le Travenues Know-how’s IPO contains contemporary issuance of shares value ₹750 crore and an offer-for-sale (OFS) of fairness shares to the tune of ₹850 crore by current shareholders.
As a part of the OFS, Saif Companions India IV will offload shares value ₹550 crore, Micromax Informatics will promote shares for ₹200 crore and Aloke Bajpai and Rajnish Kumar will divest stakes value ₹50 crore every.
At the moment, SAIF Companions holds 23.97 per cent within the firm, Micromax 7.61 per cent, Aloke Bajpai 9.18 per cent and Rajnish Kumar 8.79 per cent stake within the agency.
The proceeds of the contemporary problem might be used to fund the corporate’s natural and inorganic progress initiatives and for normal company functions.
Sahajanand Medical Applied sciences’ preliminary share-sale consists of contemporary issuance of fairness shares value ₹410.33 crore and an offer-for-sale of fairness shares to the tune of ₹1,089.67 crore by promoting shareholders.
Below the OFS, Samara Capital Markets Holding will promote shares value ₹635.56 crore and Nhpea Sparkle Holdings B.V will offload shares to the tune of ₹320.36 crore, amongst others.
At the moment, Samara Capital holds a 36.59 per cent stake within the firm and NHPEA Sparkle Holding BV owns an 18.44 per cent holding within the agency.
The corporate may think about a pre-IPO placement of fairness shares aggregating as much as ₹185 crore. If such placement is undertaken, the contemporary problem dimension might be decreased.
The proceeds from the contemporary problem might be utilised to pay debt, to fund the working capital necessities of the corporate’s oblique international subsidiary, Vascular Improvements Co. Ltd, and for normal company functions.
Keventer Agro’s IPO contains contemporary issuance of fairness shares value ₹350 crore and an offer-for-sale of 10,767,664 fairness shares by Mandala Swede SPV.
The proceeds of the contemporary issuance might be used to retire debt and to fund incremental capital expenditure necessities of the corporate.
This story has been revealed from a wire company feed with out modifications to the textual content. Solely the headline has been modified.
Supply: Live Mint